United States Biotechnology & Medical Research

Fractyl Health Inc (GUTS)

Track

Track

Fractyl Health Inc. recorded eight insider trading transactions over the past ninety days, all representing open market purchases totaling approximately $185,019. Executives and other insiders acquired shares despite a 15.6% decline in stock price. These acquisitions follow a recent earnings report where the company outperformed expectations by 20%.
Ticker: GUTS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fractyl Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Royan Ajay Non-Executive Director
Transaction date
Purchase
Price
183.63
Quantity 56,409 -29.9%
Value US$4,273,210
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
340.61
Quantity 778 +18.9%
Value US$2,689,485
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
237.33
Quantity 73,487 +37.4%
Value US$4,192,085
Sheffield Ian Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 35,000 +inf%
Value US$25,529
Sheffield Ian Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 35,000 +inf%
Value US$25,529
3.1
BRADLEY WILLIAM Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 68,493 +424.7%
Value US$50,329
3.1
BRADLEY WILLIAM Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 68,493 +424.7%
Value US$50,329
Smith Weber Lara Chief Financial Officer Officer
Transaction date
Purchase
Price
0.69
Quantity 20,000 +inf%
Value US$13,708
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.92
Quantity 10,416 +2.1%
Value US$19,999
2.5
Royan Ajay Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.28
Quantity 17,901 +inf%
Value US$22,980
2.3
Barnes Kelly Ann Non-Executive Director
Transaction date
Purchase
Price
1.30
Quantity 31,000 +inf%
Value US$40,210
2.7
SCHULMAN AMY W Non-Executive Director
Transaction date
Purchase
Price
1.17
Quantity 8,550 +inf%
Value US$9,964
2.4
Conaway Samuel Non-Executive Director
Transaction date
Purchase
Price
1.17
Quantity 8,550 +inf%
Value US$9,964
3.1
BRADLEY WILLIAM Non-Executive Director
Transaction date
Purchase
Price
1.26
Quantity 16,129 +inf%
Value US$20,358
3.7
Caplan Jay David President, Chief Product Off. Officer
Transaction date
Planned sale
Price
1.81
Quantity 22,346 -12.7%
Value US$40,464
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.82
Quantity 90,972 -15.6%
Value US$165,205
3.7
Caplan Jay David President, Chief Product Off. Officer
Transaction date
Planned sale
Price
1.95
Quantity 21,472 -12.3%
Value US$41,802
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.95
Quantity 20,948 -4.1%
Value US$40,798
3.5
HARITH RAJAGOPALAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
2.02
Quantity 111,920
Value US$226,078
3.7
JAY CAPLAN Officer Officer
Transaction date
Proposed sale
Price
2.02
Quantity 43,818
Value US$88,512
3.5
Rajagopalan Harith Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.47
Quantity 96,517 -16.4%
Value US$238,358
3.7
Caplan Jay David President, Chief Product Off. Officer
Transaction date
Sale
Price
2.47
Quantity 64,197 -29.5%
Value US$158,541
3.7
Caplan Jay David President, Chief Product Off. Officer
Transaction date
Sale
Price
2.90
Quantity 65,000 -68.1%
Value US$188,474
3.7
JAY D CAPLAN Officer Officer
Transaction date
Proposed sale
Price
2.85
Quantity 65,000
Value US$185,213
0.9
Elia Marc Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 466,666 +33.6%
Value US$6,999,990
Mithril LP Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 333,333 +36.3%
Value US$4,999,995
2.5
Royan Ajay Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 333,333 +36.3%
Value US$4,999,995
CVF, LLC (4) Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 333,333 +7.7%
Value US$4,999,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase
2.5
Royan Ajay
Non-Executive Director
56,409 -29.9%
183.63
US$4,273,210 		56,409 -29.9% 183.63 US$4,273,210
2026-06-11 2026-06-10 PP Planned purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
778 +18.9%
340.61
US$2,689,485 		778 +18.9% 340.61 US$2,689,485
2026-06-11 2026-06-10 PP Planned purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
73,487 +37.4%
237.33
US$4,192,085 		73,487 +37.4% 237.33 US$4,192,085
2026-06-11 2026-06-10 B Purchase
Sheffield Ian
Non-Executive Director
35,000 +inf%
0.73
US$25,529 		35,000 +inf% 0.73 US$25,529
2026-06-11 2026-06-10 B Purchase
Sheffield Ian
Non-Executive Director
35,000 +inf%
0.73
US$25,529 		35,000 +inf% 0.73 US$25,529
2026-06-11 2026-06-10 B Purchase
3.1
BRADLEY WILLIAM
Non-Executive Director
68,493 +424.7%
0.73
US$50,329 		68,493 +424.7% 0.73 US$50,329
2026-06-11 2026-06-10 B Purchase
3.1
BRADLEY WILLIAM
Non-Executive Director
68,493 +424.7%
0.73
US$50,329 		68,493 +424.7% 0.73 US$50,329
2026-06-09 2026-06-08 B Purchase
Smith Weber Lara

Chief Financial Officer

Officer
20,000 +inf%
0.69
US$13,708 		20,000 +inf% 0.69 US$13,708
2025-12-08 2025-12-04 B Purchase
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
10,416 +2.1%
1.92
US$19,999 		10,416 +2.1% 1.92 US$19,999
2025-03-18 2025-03-14 B Purchase
2.5
Royan Ajay
Non-Executive Director Large shareholder
17,901 +inf%
1.28
US$22,980 		17,901 +inf% 1.28 US$22,980
2025-03-18 2025-03-14 B Purchase
2.3
Barnes Kelly Ann
Non-Executive Director
31,000 +inf%
1.30
US$40,210 		31,000 +inf% 1.30 US$40,210
2025-03-17 2025-03-13 B Purchase
2.7
SCHULMAN AMY W
Non-Executive Director
8,550 +inf%
1.17
US$9,964 		8,550 +inf% 1.17 US$9,964
2025-03-17 2025-03-13 B Purchase
2.4
Conaway Samuel
Non-Executive Director
8,550 +inf%
1.17
US$9,964 		8,550 +inf% 1.17 US$9,964
2025-03-17 2025-03-13 B Purchase
3.1
BRADLEY WILLIAM
Non-Executive Director
16,129 +inf%
1.26
US$20,358 		16,129 +inf% 1.26 US$20,358
2025-02-03 2025-01-31 PlS Planned sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
22,346 -12.7%
1.81
US$40,464 		22,346 -12.7% 1.81 US$40,464
2025-02-03 2025-01-31 PlS Planned sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
90,972 -15.6%
1.82
US$165,205 		90,972 -15.6% 1.82 US$165,205
2025-02-03 2025-01-30 PlS Planned sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
21,472 -12.3%
1.95
US$41,802 		21,472 -12.3% 1.95 US$41,802
2025-02-03 2025-01-30 PlS Planned sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
20,948 -4.1%
1.95
US$40,798 		20,948 -4.1% 1.95 US$40,798
2025-01-30 2025-01-30 PrS Proposed sale
3.5
HARITH RAJAGOPALAN

Director; Officer

Executive Director
111,920
2.02
US$226,078 		111,920 2.02 US$226,078
2025-01-30 2025-01-30 PrS Proposed sale
3.7
JAY CAPLAN

Officer

Officer
43,818
2.02
US$88,512 		43,818 2.02 US$88,512
2024-11-13 2024-11-11 S Sale
3.5
Rajagopalan Harith

Chief Executive Officer

Executive Director
96,517 -16.4%
2.47
US$238,358 		96,517 -16.4% 2.47 US$238,358
2024-11-13 2024-11-11 S Sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
64,197 -29.5%
2.47
US$158,541 		64,197 -29.5% 2.47 US$158,541
2024-09-13 2024-09-12 S Sale
3.7
Caplan Jay David

President, Chief Product Off.

Officer
65,000 -68.1%
2.90
US$188,474 		65,000 -68.1% 2.90 US$188,474
2024-09-12 2024-09-12 PrS Proposed sale
3.7
JAY D CAPLAN

Officer

Officer
65,000
2.85
US$185,213 		65,000 2.85 US$185,213
2024-02-08 2024-02-06 B Purchase
0.9
Elia Marc
Non-Executive Director
466,666 +33.6%
15.00
US$6,999,990 		466,666 +33.6% 15.00 US$6,999,990
2024-02-08 2024-02-06 B Purchase
Mithril LP
Large shareholder
333,333 +36.3%
15.00
US$4,999,995 		333,333 +36.3% 15.00 US$4,999,995
2024-02-08 2024-02-06 B Purchase
2.5
Royan Ajay
Non-Executive Director Large shareholder
333,333 +36.3%
15.00
US$4,999,995 		333,333 +36.3% 15.00 US$4,999,995
2024-02-06 2024-02-06 B Purchase
CVF, LLC

(4)

Large shareholder
333,333 +7.7%
15.00
US$4,999,995 		333,333 +7.7% 15.00 US$4,999,995
Explore more

More insider trading research around Fractyl Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America